Cortexyme Stock Predictions

Healthcare > Biotechnology

Buy CRTX

*Your capital is at risk

$2.20

+0 (+0%)

At Close: Nov 04, 2022

Currently predicting for Mon, 8 Jun 2026

CRTX Prediction Chart

CRTX Predictions History

Latest community submissions for CRTX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Mar 3, 2022	$4.69 +2.18%	$4.30	X	90.93%	0
lhamotopgyal.263000	Mar 3, 2022	Bullish	$4.30	X	—	1
Anthony Harriman @AnthonyHarriman.305741	Mar 3, 2022	Bullish	$4.30	X	—	1
Andrea Winder @AndreaWinder.174444	Mar 3, 2022	Bullish	$4.30	X	—	1
JS Pro	Jan 7, 2022	$11.90 -1.24%	$12.05	X	98.76%	1
prinzipisch.286103	Jan 7, 2022	Bullish	$12.05	X	—	1
JS Pro	Jul 16, 2021	$50.99 -4.76%	$53.54	X	95.24%	0
sounder	Jul 16, 2021	$55.02 +2.76%	$53.54	X	97.24%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CRTX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CORTEXYME INC.

Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's and other degenerative diseases. Its lead drug candidate is atuzaginstat (COR388), an orally administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III clinical trial for use in patients with mild to moderate Alzheimer's disease, as well as for the treatment of oral squamous cell carcinoma, periodontitis...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
FISV	0%	Nov 30
K KEEL	0%	Nov 30
D DFTX	0%	Nov 30
R RKLZ	0%	Nov 30
R RKTO	0%	Nov 30

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by